<!DOCTYPE html>
<html lang="en">
<head>
    <link href="./style.css" type="text/css" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Montserrat" rel="stylesheet">
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>Palmer Lab</title>
</head>
<body>
    <header>
            <div class="topnav">
                    <a href="#research">Research Interests
                    </a>
                    <a href="#members">Lab Members
                    </a>
                    <a href="#projects">Projects
                    </a>
                    <a href="#microbes">Microbes
                    </a>
                    <a href="#databases">Databases
                    </a>
                    <a href="#publications">Publications
                    </a>
                </div>
        
        <h1>Dr. Glen Palmer's Lab</h1>
        
    </header>
<main>
    <article>
        <section>
            <a name = "research"></a>
            <h3>Research Interests</h3>
            <p>
                Dr. Palmerâ€™s research focuses on the opportunistic fungal pathogen Candida albicans, which causes serious mucosal disease and fatal systemic infections. Much of his research addresses the role played by the fungal vacuole, an acidic cellular compartment rich in degradative enzymes, in supporting C. albicans ability to survive within and injure mammalian tissue. This has revealed that normal vacuolar function is essential for C. albicans colonization and invasion of mammalian tissue. In addition, specific vacuolar pathways may also determine fungal susceptibility to conventional forms of antifungal therapy. As mammalian cells lack vacuoles, this organelle may provide a target that can be exploited to develop new, pathogen selective antifungal agents. To this end, a major goal of current efforts within the lab is to identify chemical agents that disrupt the integrity of the fungal vacuole, and assess their potential as novel antifungal therapies.
            <br>    
            <br>    
                A second major interest of the Palmer lab is in devising novel yeast based chemical-genetic screening strategies that can be applied to drug discovery.
            </p>
            
        </section>
        
        
        <section>
            <a name = "members"></a>
            <h3>Lab Members</h3>
            
                    <div class="gallery">
                        <img src="glen.jpg" alt="Picture of Dr. Glen Palmer." width="197" height="225"><figcaption>Dr. Glen Palmer</figcaption>
                    </div>
                    <div class="gallery">
                        <img src="Christian.jpeg" alt="Picture of Christian" width="197" height="225"><figcaption>Christian</figcaption>
                    </div>
                    <div class="gallery"><img src="Parker.jpg" alt="Picture of Parker" width="197" height="225"><figcaption>Parker</figcaption>
                    </div>
                    <div class="gallery">
                        <a href="tracy.html"><img src="Tracy.jpg" alt="Picture of Tracy" width="197" height="225"><figcaption>Tracy</figcaption>
                        </a>
                    </div>
                    
        </section>
        <section>
                <a name = "projects"></a>
                <h3>Projects</h3>

            </section>
        <section>
                <a name = "microbes"></a>
                <h3>Microbes</h3>

                <div class="gallery">
                        <img src="albicans.jpg" alt="Picture of Candida albicans." width="200" height="200"><figcaption><em>Candida albians</em></figcaption>
                    </div>
                    <div class="gallery">
                        <img src="auris.jpg" alt="Picture of Candida auris." width="200" height="200"><figcaption><em>Candida auris</em></figcaption>
                    </div>
                    <div class="gallery"><img src="glabrata.jpg" alt="Picture of Candida glabrata." width="200" height="200"><figcaption><em>Candida glabrata</em></figcaption>
                    </div>
                    <div class="gallery">
                        <img src="crypto.jpg" alt="Picture of Cryptococcus neoformans." width="200" height="200"><figcaption><em>Cryptococcus neoformans</em></figcaption>
                    </div>
                    
            
            </section>
            <section>
                <a name = "databases" ></a>
                    <h3>Databases</h3>

                    <p class="databases">
                        Bacterial Strains
                        <br>
                        Yeast Strains
                        <br>
                        <a href=PrimerDatabase_List.xlsx>Primers</a>
                    </p>
                </section>
                <section>
                        <a name = "publications"></a>
                        <h3 id="pub_color">Publications</h3>
                        <ol>
                            <li>
                                Butts A, Reitler P, Nishimoto AT, DeJarnette C, Estredge LR, Peters TL, Veve
                                MP, Rogers PD, <strong>Palmer GE</strong>. A systematic screen reveals a diverse collection of
                                medications induce antifungal resistance in Candida species. Antimicrob Agents
                                Chemother. 2019 Mar 11. pii: AAC.00054-19. doi: 10.1128/AAC.00054-19. [Epub ahead
                                of print] PubMed PMID: 30858206.
                            </li>
                            <br>
                            <li>
                                Luna-Tapia A, Kerns ME, Eberle KE, Jursic BS, <strong>Palmer GE</strong>. Trafficking through
                                the late endosome significantly impacts Candida albicans tolerance of the azole
                                antifungals. Antimicrob Agents Chemother. 2015 Apr;59(4):2410-20. doi:
                                10.1128/AAC.04239-14. Epub 2015 Feb 9. PubMed PMID: 25666149; PubMed Central
                                PMCID: PMC4356793.
                            </li>
                            <br>
                            <li>
                                Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC,
                                Fidel PL Jr, <strong>Palmer GE</strong>. ERG2 and ERG24 Are Required for Normal Vacuolar
                                Physiology as Well as Candida albicans Pathogenicity in a Murine Model of
                                Disseminated but Not Vaginal Candidiasis. Eukaryot Cell. 2015 Oct;14(10):1006-16.
                                doi: 10.1128/EC.00116-15. Epub 2015 Jul 31. PubMed PMID: 26231054; PubMed Central
                                PMCID: PMC4588627.
                            </li>
                            <br>
                            <li>
                                Butts A, <strong>Palmer GE</strong>, Rogers PD. Antifungal adjuvants: Preserving and extending 
                                the antifungal arsenal. Virulence. 2017 Feb 17;8(2):198-210. doi:
                                10.1080/21505594.2016.1216283. Epub 2016 Jul 26. Review. PubMed PMID: 27459018;
                                PubMed Central PMCID: PMC5354161.
                            </li> 
                            <br>
                            <li>
                                Luna-Tapia A, Tournu H, Peters TL, <strong>Palmer GE</strong>. Endosomal Trafficking Defects
                                Can Induce Calcium-Dependent Azole Tolerance in Candida albicans. Antimicrob
                                Agents Chemother. 2016 Nov 21;60(12):7170-7177. Print 2016 Dec. PubMed PMID:
                                27645241; PubMed Central PMCID: PMC5118996.
                            </li>  
                            <br>
                            <li>   
                                Tournu H, Carroll J, Latimer B, Dragoi AM, Dykes S, Cardelli J, Peters TL,
                                Eberle KE, <strong>Palmer GE</strong>. Identification of small molecules that disrupt vacuolar
                                function in the pathogen Candida albicans. PLoS One. 2017 Feb 2;12(2):e0171145.
                                doi: 10.1371/journal.pone.0171145. eCollection 2017. PubMed PMID: 28151949;
                                PubMed Central PMCID: PMC5289544.    
                            </li>  
                            <br>
                            <li>     
                                Peters BM, Luna-Tapia A, Tournu H, Rybak JM, Rogers PD, <strong>Palmer GE</strong>. An
                                Azole-Tolerant Endosomal Trafficking Mutant of Candida albicans Is Susceptible to
                                Azole Treatment in a Mouse Model of Vaginal Candidiasis. Antimicrob Agents
                                Chemother. 2017 May 24;61(6). pii: e00084-17. doi: 10.1128/AAC.00084-17. Print
                                2017 Jun. PubMed PMID: 28348159; PubMed Central PMCID: PMC5444139.   
                            </li>  
                            <br>
                            <li>      
                                Rybak JM, Dickens CM, Parker JE, Caudle KE, Manigaba K, Whaley SG, Nishimoto
                                AT, Luna-Tapia A, Roy S, Zhang Q, Barker KS, <strong>Palmer GE</strong>, Sutter TR, Homayouni R,
                                Wiederhold NP, Kelly SL, Rogers PD. Loss of C-5 Sterol Desaturase Activity
                                Results in Increased Resistance to Azole and Echinocandin Antifungals in a
                                Clinical Isolate of Candida parapsilosis. Antimicrob Agents Chemother. 2017 Aug
                                24;61(9). pii: e00651-17. doi: 10.1128/AAC.00651-17. Print 2017 Sep. PubMed PMID:
                                28630186; PubMed Central PMCID: PMC5571332.    
                            </li>  
                            <br>
                            <li>    
                                Tournu H, Luna-Tapia A, Peters BM, <strong>Palmer GE</strong>. In Vivo Indicators of
                                Cytoplasmic, Vacuolar, and Extracellular pH Using pHluorin2 in Candida albicans. 
                                mSphere. 2017 Jul 5;2(4). pii: e00276-17. doi: 10.1128/mSphere.00276-17.
                                eCollection 2017 Jul-Aug. PubMed PMID: 28685162; PubMed Central PMCID:
                                PMC5497024.
                            </li>  
                            <br>
                            <li>    
                                Butts A, Reitler P, Ge W, Fortwendel JR, <strong>Palmer GE</strong>. Commonly Used Oncology
                                Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species. 
                                Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00504-18. doi:
                                10.1128/AAC.00504-18. Print 2018 Jul. PubMed PMID: 29712657; PubMed Central
                                PMCID: PMC6021626.  
                            </li>

                        </ul>  
                    </section>
                    
    </article>

</main>   
</body>
</html>
<footer>&copy;2019 Tracy Peters</footer>





